Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL
<p>Manufacturing schema for the clinical trial</p>
保存先:
| 第一著者: | |
|---|---|
| その他の著者: | , , , , , , , , , , , , , , , , , , , , |
| 出版事項: |
2025
|
| 主題: | |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
| _version_ | 1849927633278599168 |
|---|---|
| author | Ibrahim Aldoss (15055961) |
| author2 | Samer K. Khaled (15055964) Xiuli Wang (15055967) Joycelynne Palmer (15055970) Yan Wang (15055973) Jamie R. Wagner (15055976) Mary C. Clark (15055979) Jennifer Simpson (15055982) Jinny Paul (15055985) Vibhuti Vyas (15055988) Sheng-Hsuan Chien (15055991) Anthony Stein (15055994) Vinod Pullarkat (15047900) Amandeep Salhotra (15055997) Monzr M. Al Malki (15056000) Ahmed Aribi (15056003) Karamjeet Sandhu (15056006) Sandra H. Thomas (15056009) Lihua E. Budde (15056012) Guido Marcucci (11252666) Christine E. Brown (15056015) Stephen J. Forman (15056018) |
| author2_role | author author author author author author author author author author author author author author author author author author author author author |
| author_facet | Ibrahim Aldoss (15055961) Samer K. Khaled (15055964) Xiuli Wang (15055967) Joycelynne Palmer (15055970) Yan Wang (15055973) Jamie R. Wagner (15055976) Mary C. Clark (15055979) Jennifer Simpson (15055982) Jinny Paul (15055985) Vibhuti Vyas (15055988) Sheng-Hsuan Chien (15055991) Anthony Stein (15055994) Vinod Pullarkat (15047900) Amandeep Salhotra (15055997) Monzr M. Al Malki (15056000) Ahmed Aribi (15056003) Karamjeet Sandhu (15056006) Sandra H. Thomas (15056009) Lihua E. Budde (15056012) Guido Marcucci (11252666) Christine E. Brown (15056015) Stephen J. Forman (15056018) |
| author_role | author |
| dc.creator.none.fl_str_mv | Ibrahim Aldoss (15055961) Samer K. Khaled (15055964) Xiuli Wang (15055967) Joycelynne Palmer (15055970) Yan Wang (15055973) Jamie R. Wagner (15055976) Mary C. Clark (15055979) Jennifer Simpson (15055982) Jinny Paul (15055985) Vibhuti Vyas (15055988) Sheng-Hsuan Chien (15055991) Anthony Stein (15055994) Vinod Pullarkat (15047900) Amandeep Salhotra (15055997) Monzr M. Al Malki (15056000) Ahmed Aribi (15056003) Karamjeet Sandhu (15056006) Sandra H. Thomas (15056009) Lihua E. Budde (15056012) Guido Marcucci (11252666) Christine E. Brown (15056015) Stephen J. Forman (15056018) |
| dc.date.none.fl_str_mv | 2025-11-25T13:07:06Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30707522 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/figure/Supplemental_Figure_S1_from_Favorable_Activity_and_Safety_Profile_of_Memory-Enriched_CD19-Targeted_Chimeric_Antigen_Receptor_T-Cell_Therapy_in_Adults_with_High-Risk_Relapsed_Refractory_ALL/30707522 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Immuno-oncology Clinical Research and Trials Clinical Trial Results Hematological Cancers Leukemias Immunotherapy Cellular immunotherapy Engineered/CAR T cells |
| dc.title.none.fl_str_mv | Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL |
| dc.type.none.fl_str_mv | Image Figure info:eu-repo/semantics/publishedVersion image |
| description | <p>Manufacturing schema for the clinical trial</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_8a79888b2c5442b183c8cf73075acbcc |
| identifier_str_mv | 10.1158/1078-0432.30707522 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30707522 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALLIbrahim Aldoss (15055961)Samer K. Khaled (15055964)Xiuli Wang (15055967)Joycelynne Palmer (15055970)Yan Wang (15055973)Jamie R. Wagner (15055976)Mary C. Clark (15055979)Jennifer Simpson (15055982)Jinny Paul (15055985)Vibhuti Vyas (15055988)Sheng-Hsuan Chien (15055991)Anthony Stein (15055994)Vinod Pullarkat (15047900)Amandeep Salhotra (15055997)Monzr M. Al Malki (15056000)Ahmed Aribi (15056003)Karamjeet Sandhu (15056006)Sandra H. Thomas (15056009)Lihua E. Budde (15056012)Guido Marcucci (11252666)Christine E. Brown (15056015)Stephen J. Forman (15056018)CancerImmuno-oncologyClinical Research and TrialsClinical Trial ResultsHematological CancersLeukemiasImmunotherapyCellular immunotherapyEngineered/CAR T cells<p>Manufacturing schema for the clinical trial</p>2025-11-25T13:07:06ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30707522https://figshare.com/articles/figure/Supplemental_Figure_S1_from_Favorable_Activity_and_Safety_Profile_of_Memory-Enriched_CD19-Targeted_Chimeric_Antigen_Receptor_T-Cell_Therapy_in_Adults_with_High-Risk_Relapsed_Refractory_ALL/30707522CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307075222025-11-25T13:07:06Z |
| spellingShingle | Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL Ibrahim Aldoss (15055961) Cancer Immuno-oncology Clinical Research and Trials Clinical Trial Results Hematological Cancers Leukemias Immunotherapy Cellular immunotherapy Engineered/CAR T cells |
| status_str | publishedVersion |
| title | Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL |
| title_full | Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL |
| title_fullStr | Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL |
| title_full_unstemmed | Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL |
| title_short | Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL |
| title_sort | Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL |
| topic | Cancer Immuno-oncology Clinical Research and Trials Clinical Trial Results Hematological Cancers Leukemias Immunotherapy Cellular immunotherapy Engineered/CAR T cells |